113081-49-5 Usage
General Description
Benzene, 1-bromo-4-(chloromethyl)-2-methoxy- is a chemical compound with the molecular formula C8H8BrClO. It is a derivative of benzene, with a bromine atom attached to the first carbon, a chloromethyl group attached to the fourth carbon, and a methoxy group attached to the second carbon. Benzene, 1-bromo-4-(chloromethyl)-2-methoxy- is commonly used in organic synthesis and pharmaceutical research. It is important to handle this chemical with caution as it is potentially hazardous, with risks of irritation to the skin, eyes, and respiratory system, and may have toxic effects if swallowed or inhaled. Additionally, it can be harmful to aquatic life and may persist in the environment. Therefore, proper safety measures and handling procedures should be followed when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 113081-49-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,0,8 and 1 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 113081-49:
(8*1)+(7*1)+(6*3)+(5*0)+(4*8)+(3*1)+(2*4)+(1*9)=85
85 % 10 = 5
So 113081-49-5 is a valid CAS Registry Number.
113081-49-5Relevant articles and documents
COMPOUNDS AND THEIR METHODS OF USE
-
Page/Page column 96-97, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persis
COMPOUNDS AND THEIR METHODS OF USE
-
Page/Page column 137, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
TRIAZOLOPYRIDINES
-
Page/Page column 132-133, (2012/11/07)
The present invention relates to triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said com